Valuation (91%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.80 | N/A |
| PEG Ratio (TTM) | 0.16 | N/A |
| P/S Ratio (TTM) | 3.03 | N/A |
| P/B Ratio (TTM) | 0.90 | N/A |
| P/FCF Ratio (TTM) | 8.23 | N/A |
| Price to 5YR AVG Earnings Ratio | 17.12 | N/A |
| Price to 5YR AVG FCF Ratio | 7.38 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.59% | N/A |
| ROE (TTM) | 6.47% | N/A |
| Net Profit Margin (TTM) | 21.95% | N/A |
| ROIC 5YR AVG | 3.23% | N/A |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 232.29% | 650.40% | 391.15% |
| Revenue | 385.76% | 189.39% | 362.21% |
| Net Income | 231.82% | 669.71% | 402.77% |
| Cash Flow | 702.16% | 82.14% | 96.72% |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.34 | N/A |
| Quick Ratio (TTM) | 4.34 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 1.48 | N/A |
| Piotroski F-Score | 9 | N/A |
| Altman Z-Score | 0.48 | N/A |
| LTL to 5YR AVG FCF | 12.38 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.28% | N/A |